Neuramedy
About:
Neuramedy provides research on neurodegenerative disorders focused on alpha-synuclein and related mechanisms for Parkinson's disease.
Website: http://www.neuramedy.com
Top Investors: TIPS Program, Hana Ventures, Industrial Bank of Korea, STIC Ventures, Devsisters Ventures
Description:
Neuramedy develops medical supplies and lifescience.
Total Funding Amount:
8B KRW
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Songdong, Seoul-t'ukpyolsi, South Korea
Founded Date:
2019-01-01
Contact Email:
contact(AT)neuramedy.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2020-07-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai